Motley Fool Asset Management LLC Abb Vie Inc. Transaction History

Motley Fool Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $2.01 Million - $2.69 Million	-27,444 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $1.77 Million - $2.68 Million	27,444 New	27,444 $2.09 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $1.77 Million - $2.13 Million	-28,110 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $1.85 Million - $2.36 Million	28,110 New	28,110 $2.04 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Motley Fool Asset Management LLC with notifications on news.